Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NRXP compared with CLLS: revenue, margins and what each company keeps, and the suppliers and customers both name
NRXP
NRX Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
CLLS
Cellectis S.A.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NRXP
NRX Pharmaceuticals, Inc.
vs
CLLS
Cellectis S.A.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
NRXP
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±34.2%
▲
+4.89%
×0.14
CLLS
No earnings history for CLLS.
= implied
NRXP realized, solid
CLLS realized, hatched
One scale, both sides: full bar = 35%
× = |realized| ÷ implied
Source: market data
NRXP
NRX Pharmaceuticals, Inc.
Change
2.29
▼
−8.03%
· post 2.26
Mkt cap
$107.8M
Revenue
$6,000
Q2 FY26
CLLS
Cellectis S.A.
Change
1.03
▼
−12.24%
· post 1.03
Closed
Nov 5 '26
Mkt cap
$103.3M
Revenue
—
vs
Compare
Closed
Nov 5 '26
NRXP
NRX Pharmaceuticals, Inc.
vs
CLLS
Cellectis S.A.
2.29
▼
−8.03%
post 2.26
Price
1.03
▼
−12.24%
post 1.03
$107.8M
Mkt cap
$103.3M
Q2 FY26
$6,000
Revenue
—
Change
Change
NRXP
2.29
▼
−8.03%
vs
CLLS
1.03
▼
−12.24%
Closed
Nov 5 '26